Navigation Links
Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
Date:9/21/2007

SAN DIEGO, Sept. 21 /PRNewswire/ -- ChemDiv, Inc. (San Diego) announced today that its Chemical Diversity Research Institute (CDRI, Moscow) is undertaking a partnership with the Blokhin Russian Oncology Center (RONC) of the Russian Academy of Medical Sciences, the US Department of Energy (DOE), and the US National Cancer Institute (NCI) to develop novel small molecule therapies for the prevention and treatment of prostate cancer (PRC). The partnership will operate under the auspices of The Global Initiatives for Proliferation Prevention Program.

PRC is the most frequently occurring cancer among males in developed countries and accounts for nine percent of cancer deaths in men, second only to lung cancers. PRC is frequently asymptomatic in the early stages, and later stage diagnosis greatly reduces the efficacy of available therapeutic methods.

This project sets a vivid example of international cooperation between leading Russian and U.S. research centers in medical science research aimed at life threatening diseases. CDRI and its collaborators will deploy post-genome technologies including rational drug design and medicinal chemistry, chemical genomics and systems biology to support efficient preclinical discovery and development programs. The American partners from the Oak Ridge National Laboratory (ORNL, DOE) will provide a knowledge base system for chemical and biological information, using Modular Chemical Descriptor Language technology. Experts from other Russian leading academic research institutions and the NCI will be engaged in the project.

"ChemDiv and CDRI established a long track record of success in lead discovery, with specific expertise in oncology pathway chemistry and biology," said Dmitry Kravchenko, General Director of CDRI. "This opportunity allows us to expand our collaboration with the leading experts in oncology and rational drug design in an especially meaningful context -- targeting a major unmet need for new approac
'/>"/>

SOURCE ChemDiv, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chemical in Gila monsters saliva yields Alzheimer drug
2. Biochemical Markers Might Help Predict Heart Problems
3. Chemical found in plants may be the treatment for leukemia
4. Chemicals in clear plastics can cause learning difficulties
5. Harmful chemicals change the genetic response to hormone estrogen
6. Quitting Smoking Made Easy By Track Of New Chemical
7. Brain Chemical Identified For Drug Dependent Behavior
8. Toxic chemicals found in domestic products poisoning newborn babies
9. Block Immune System Chemical For Treating Asthma
10. Chest Pain Can Be Identified By New Tracer Chemical 30 Hours After Pain Relief
11. Cancer Causing Proteins Trigger Abnormal Biochemical Reactions In Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ectually disabled Australians will soon enjoy bett...new Medicare rebate created// at the AMA’s urging,...group, people with an intellectual disability have...any Australians, mostly because they can find it d...
... with mesothelioma — a form of cancer associated w...e when treated with a combination// of two cancer ...ma, a rare but aggressive form of cancer that occu...gs, heart and abdomen, is associated with exposure...
... A botched up family planning operation would have...ing British doctor of Indian origin// wasn't there...ctor Ashok Vardhan's visit to Purnea district, 300...ti Devi, who was comatose after a portion of her l...
...ientists have come out strongly against the NHS's ...r to those in the age group 25 to 29, leaving// o...e doctors, Consultant cytopathologists Amanda Herb...dation Trust in London, and John Smith, from the R...
Other Medicine News:Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 2Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 3Health News:Extend Cervical Smears to Younger Women, Insist Specialists 2
(Date:9/4/2008)...Patient Identification for Targeted Therapies ...tment HUNTINGTON BEACH, Calif., and AMSTERDAM, ...rld leader in molecular cancer diagnostics,today ...nostic test that,allows physicians to quantitative...rogen receptor (ER), progesterone receptor (PR) an...
(Date:9/3/2008)...t. 3 /- Simcere,Pharmaceuti...d supplier of,branded generic pharmaceuticals and ...roduct Endu (also known as Endostar) in China,ann...al study., At the request of the SFDA, Simcere in...ate the safety and therapeutic efficacy of Endu, a...
(Date:9/3/2008)...nd GENEVA, Sept. 3 /- Artelis SA and,...based monoclonal antibody,production with the achi...er liter. This record level was accomplished by ap...igh-performance stable Selexis CHO,production cell...ists at,Selexis SA using their proprietary Selexis...
(Date:9/3/2008)...rations, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET, ...FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) annou...tions to focus on commercial and late-stage produc...ecialty pharmaceutical pain management,company. Th...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 1Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 2Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 3Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 4Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 5Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 6150 Years Later House Divided Speech Still Holds Strong Message 22081 1150 Years Later House Divided Speech Still Holds Strong Message 22081 2AHIP Selects HealthTrio to Join AHIP Solutions Program 22079 1AHIP Selects HealthTrio to Join AHIP Solutions Program 22079 2Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 1Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 2Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 3
...r , Some form of electronic hematology analy...tories. A blood cell count is usually the first sc...ut anemia or infection, and monitor cancer patient...lt to imagine medical care without this workhorse ... Early testing of sonar, developed to detect subma...
...ting Editor , ,Positive patient identificatio...dies for the past few years. Until recently, the ...eyond the reach of the average hospital or laborat...s that can be integrated into a facilitys IS requi...all facilities, while others are best for larger i...
Other Medicine Technology:Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 2Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 3Managing Preanalytical Processes for Patient Safety 2Managing Preanalytical Processes for Patient Safety 3Managing Preanalytical Processes for Patient Safety 4
...ment introduction. The design of the introducer fe...ition profile between the introducer sheath and in...h fascial tissue and strictured areas. Proximal re...ducer sheath and introducer dilator during sheath ...
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: